Candlestick · Volume · EMA · BB · VWAP · MACD · RSI · Drawing Tools
Candlestick chart with volume — data via Yahoo Finance · For educational use only
Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play
Wood trimmed stakes in Nvidia, Meta, and Tesla; instead, she added this speculative biotech play.
Oil Tumbles, Nasdaq 100 Jumps 3% As Iran Says It's Ready To Halt Hostilities: 10 Stocks Moving
WTI crude oil fell 2% after Iran's President signaled readiness to end war. Nasdaq QQQ surged 3.2% and VIX dropped 14.4%. Airlines and growth stocks led gains.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast. Moderna (NASDAQ: MRNA) has fallen 58.2% over five years. BioNTech (NASDAQ: BNTX) is down 10.9% over the same period, still below its pandemic peak. Novavax (NASDAQ: NVAX) has lost 95.3% in five years. The central question for any investor holding or considering ... 3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance
SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from cap-weighted peers and creates both opportunity and risk that investors need to understand clearly right now. The fund carries over $8 billion in assets across 150+ holdings, ... MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance
Sentiment scored by an AI model on article tone. Not investment advice.
Trade risk-free with $10,000 virtual cash.
Paper trading only — no real money involved
Open a real trading account with a regulated broker:
View Broker Options →Moderna (MRNA) is currently trading at live market price. See the live chart on this page for the latest move. Prices update live throughout market hours on this page.
Wall Street analyst consensus, AI signals, and recent news sentiment for MRNA are shown above. StockifyX surfaces the data; the decision is yours — try the call risk-free with paper trading first.
The next MRNA earnings date is shown in the Earnings section above, along with the historical EPS surprise track record.
Dividend yield, payout ratio, and ex-dividend date for MRNA are listed in the Dividends card on this page when applicable.
StockifyX gives you $10,000 in virtual cash to paper-trade MRNA at real market prices — no real money required. Click "Paper Trade" above to get started.
The latest MRNA headlines with sentiment scoring, plus the full Wall Street analyst rating breakdown, are listed further down this page.